サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血液透析および腹膜透析の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
市場調査レポート
商品コード
1377841

血液透析および腹膜透析の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）

Global Hemodialysis & Peritoneal Dialysis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 177 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血液透析および腹膜透析の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
出版日: 2023年09月01日
発行: Value Market Research
ページ情報: 英文 177 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血液透析および腹膜透析の市場規模は、2022年に953億米ドルとなり、2023～2030年にかけてCAGR 9.7%で成長し、2030年には約1,998億7,000万米ドルに達すると予測されています。

血液透析および腹膜透析は、末期腎不全（ESRD）としても知られる腎不全患者の治療に用いられる2つの異なる方法です。これらの方法はいずれも、腎臓がこの機能を効果的に果たせなくなった場合に、余分な水分とともに老廃物を体外に排出するという重要な役割を果たします。

市場力学

血液透析および腹膜透析市場は、末期腎不全（ESRD）の有病率の上昇と高度な腎代替療法の必要性を強調するさまざまな要因が重なり、大きな成長を遂げています。主な要因の1つは、高齢化、糖尿病、高血圧、生活習慣に関連した健康問題などの要因に関連して、慢性腎臓病（CKD）とESRDの発生率が増加していることです。この動向が透析治療の需要を押し上げています。透析技術の進歩も市場拡大に寄与しています。より効率的なダイアライザー、アクセスデバイスの改良、モニタリングシステムの強化などの技術革新が進み、血液透析および腹膜透析の有効性と安全性が向上しています。さらに、技術の向上、包括的なトレーニングプログラム、患者教育によって、在宅腹膜透析への移行が加速しています。患者は、在宅治療が提供する利便性と柔軟性を選ぶようになってきています。人口の高齢化、ヘルスケア支出の増加、健康保険の適用範囲の改善、患者中心のケアの重視などが、透析サービスの需要をさらに押し上げています。さらに、デジタルヘルス技術の統合、遠隔医療、透析ソリューションの革新が、腎代替療法の将来を形成しています。これらの要因は、ESRD患者の生活の質の向上において血液透析および腹膜透析市場が果たす重要な役割を裏付けています。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を網羅しています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは血液透析および腹膜透析の世界市場における各セグメントを包括的に評価することもできます。血液透析および腹膜透析産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける血液透析および腹膜透析市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 血液透析および腹膜透析 - 産業分析

  • イントロダクション - 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 血液透析および腹膜透析の世界市場分析：タイプ別

  • 概要：タイプ別
  • 実績データと予測データ
  • 分析：タイプ別
  • 血液透析
  • 腹膜透析

第6章 血液透析および腹膜透析の世界市場分析：製品別

  • 概要：製品別
  • 実績データと予測データ
  • 分析：製品別
  • デバイス
  • 消耗品

第7章 血液透析および腹膜透析の世界市場分析：最終用途別

  • 概要：最終用途別
  • 実績データと予測データ
  • 分析：最終用途別
  • 在宅ベース
  • 病院ベース

第8章 血液透析および腹膜透析の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 血液透析および腹膜透析企業の競合情勢

  • 血液透析および腹膜透析市場競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Baxter
  • B. Braun Melsungen AG
  • Fresenius Medical Care AG
  • Medtronic
  • Asahi Kasei Medical Co. Ltd.
  • Nipro Corp.
  • DaVita
  • BD
  • Nikkiso Co. Ltd.
  • Cantel Medical
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis) Market Sales by Geography (USD MN)
  • Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)) Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Device (Machine, Dialyzer, Water Treatment System, Others) Market Sales by Geography (USD MN)
  • Consumables (Bloodline, Concentrates, Catheters, Others) Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Home-based Market Sales by Geography (USD MN)
  • Hospital-based Market Sales by Geography (USD MN)
  • Global Hemodialysis & Peritoneal Dialysis Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hemodialysis & Peritoneal Dialysis Report
  • Market Research Process
  • Market Research Methodology
  • Global Hemodialysis & Peritoneal Dialysis Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis) Market Sales by Geography (USD MN)
  • Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)) Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Device (Machine, Dialyzer, Water Treatment System, Others) Market Sales by Geography (USD MN)
  • Consumables (Bloodline, Concentrates, Catheters, Others) Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Home-based Market Sales by Geography (USD MN)
  • Hospital-based Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112324

The global demand for Hemodialysis & Peritoneal Dialysis Market is presumed to reach the market size of nearly USD 199.87 BN by 2030 from USD 95.3 BN in 2022 with a CAGR of 9.7% under the study period 2023 - 2030.

Hemodialysis and peritoneal dialysis are two different methods used to treat individuals with kidney failure, also known as end-stage renal disease (ESRD). Both of these methods serve the vital purpose of eliminating waste products along with excess fluids from the body when the kidneys are no longer capable of performing this function effectively.

MARKET DYNAMICS:

The Hemodialysis and peritoneal dialysis market is experiencing significant growth due to a confluence of factors that underscore the rising prevalence of end-stage renal disease (ESRD) and the need for advanced renal replacement therapies. One of the primary drivers is the increasing incidence of chronic kidney disease (CKD) and ESRD, linked to factors like aging populations, diabetes, hypertension, and lifestyle-related health issues. This trend is propelling the demand for dialysis treatments. Advancements in dialysis technology are also contributing to market expansion. Ongoing innovations, such as more efficient dialyzers, improved access devices, and enhanced monitoring systems, are enhancing the effectiveness and safety of both hemodialysis and peritoneal dialysis. Furthermore, the shift toward home-based peritoneal dialysis is gaining momentum, driven by technological improvements, comprehensive training programs, and patient education. Patients are increasingly opting for the convenience and flexibility offered by home-based care. Aging populations, greater healthcare expenditure, improved health insurance coverage, and a focus on patient-centered care are further propelling the demand for dialysis services. Additionally, the integration of digital health technologies, telehealth, and innovations in dialysis solutions are shaping the future of renal replacement therapies. These factors collectively underscore the vital role played by the Hemodialysis and peritoneal dialysis market in improving the quality of life for individuals with ESRD.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hemodialysis & peritoneal dialysis. The growth and trends of hemodialysis & peritoneal dialysis industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the hemodialysis & peritoneal dialysis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis)
  • Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD))

By Product

  • Device (Machine, Dialyzer, Water Treatment System, Others)
  • Consumables (Bloodline, Concentrates, Catheters, Others)

By End-Use

  • Home-Based
  • Hospital-Based

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Hemodialysis & Peritoneal Dialysis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hemodialysis & Peritoneal Dialysis market include Baxter, B. Braun Melsungen AG, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd., Nipro Corp., DaVita, BD, Nikkiso Co., Ltd., Cantel Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HEMODIALYSIS & PERITONEAL DIALYSIS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis) Historic and Forecast Sales by Regions
  • 5.5 Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)) Historic and Forecast Sales by Regions

6 . GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Device (Machine, Dialyzer, Water Treatment System, Others) Historic and Forecast Sales by Regions
  • 6.5 Consumables (Bloodline, Concentrates, Catheters, Others) Historic and Forecast Sales by Regions

7 . GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-use
  • 7.4 Home-based Historic and Forecast Sales by Regions
  • 7.5 Hospital-based Historic and Forecast Sales by Regions

8 . GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE HEMODIALYSIS & PERITONEAL DIALYSIS COMPANIES

  • 9.1. Hemodialysis & Peritoneal Dialysis Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF HEMODIALYSIS & PERITONEAL DIALYSIS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Baxter
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. B. Braun Melsungen AG
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Fresenius Medical Care AG
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Medtronic
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Asahi Kasei Medical Co. Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Nipro Corp.
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. DaVita
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. BD
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Nikkiso Co. Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Cantel Medical
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies